MCID: LYM017
MIFTS: 63

Lyme Disease malady

Categories: Rare diseases, Infectious diseases, Neuronal diseases, Skin diseases

Aliases & Classifications for Lyme Disease

About this section
Sources:
2CDC, 11Disease Ontology, 13DISEASES, 30ICD10, 31ICD10 via Orphanet, 32ICD9CM, 38MedlinePlus, 39MeSH, 40MESH via Orphanet, 45NCIt, 48NIH Rare Diseases, 50Novoseek, 54Orphanet, 62SNOMED-CT, 68UMLS, 69UMLS via Orphanet
See all MalaCards sources

Aliases & Descriptions for Lyme Disease:

Name: Lyme Disease 11 48 54 50 38 2 39 13 68
Lyme Neuroborreliosis 11 50 39 68
Lyme Borreliosis 11 48 54 13
Neuroborreliosis 11 68
Borreliosis 48 50
 
Neurological Lyme Disease 11
Bannworth's Syndrome 11
Borrelia Infections 68
Bannwarth Syndrome 11

Characteristics:

Orphanet epidemiological data:

54
lyme disease:
Inheritance: Not applicable; Prevalence: >1/1000 (Europe),1-5/10000 (France); Age of onset: All ages

Classifications:



External Ids:

Disease Ontology11 DOID:11729
ICD1030 A69.2, A69.20
ICD9CM32 088.81
NCIt45 C45161
Orphanet54 ORPHA91546
MESH via Orphanet40 D008193
UMLS via Orphanet69 C0024198
ICD10 via Orphanet31 A69.2

Summaries for Lyme Disease

About this section
MedlinePlus:38 Lyme disease is a bacterial infection you get from the bite of an infected tick. the first symptom is usually a red rash, which may look like a bull's eye. but not all people with lyme disease have a rash. as the infection spreads to other parts of the body, you may have a fever a headache body aches a stiff neck fatigue lyme disease can be hard to diagnose because many of its symptoms are like those of the flu and other diseases. and you may not have noticed a tick bite. your health care provider will look at your symptoms and medical history to figure out whether you have lyme disease. lab tests may not always give a clear answer until you have been infected for at least a few weeks. antibiotics can cure most cases of lyme disease. the sooner treatment begins, the quicker and more complete the recovery. after treatment, some patients may still have muscle or joint aches and nervous system symptoms. this is called post-treatment lyme disease syndrome (ptlds). long-term antibiotics have not been shown to help with ptlds. however, there are ways to help with the symptoms of ptlds, and most patients do get better with time. nih: national institute of allergy and infectious diseases

MalaCards based summary: Lyme Disease, also known as lyme neuroborreliosis, is related to babesiosis and spotted fever, and has symptoms including hypermelanotic macule, meningitis and arthritis. An important gene associated with Lyme Disease is YBX3 (Y-Box Binding Protein 3), and among its related pathways are IL-9 Signaling Pathways and their Primary Biological Effects in Different Immune Cell Types and LDL Oxidation in Atherogenesis. Affiliated tissues include skin, testes and heart, and related mouse phenotypes are renal/urinary system and cardiovascular system.

Disease Ontology:11 A primary bacterial infectious disease that results in infection, has material basis in Borrelia burgdorferi, which is transmitted by blacklegged tick (Ixodes scapularis) or transmitted by western blacklegged tick (Ixodes pacificus). The infection has symptom fever, has symptom headache, has symptom fatigue, and has symptom skin rash called erythema migrans. If left untreated, infection can spread to joints, the heart, and the nervous system.

NIH Rare Diseases:48 Lyme disease is the most common tickborne infectious disease in the United States. Early signs and symptoms of the condition include fever, chills, muscle pain, headache, and joint pain. As the condition progresses, affected people may experience heart problems, Bell's palsy, arthritis, abnormal muscle movement, speech problems and cognitive (thinking) abnormalities. Please visit the Center for Disease Control and Prevention's Web site for a more comprehensive list of symptoms. Lyme disease is caused by the bacterium Borrelia burgdorferi, which is transmitted to humans through the bite of infected blacklegged ticks. Certain features of the condition, including whether or not an affected person will develop medication-resistant chronic arthritis, is thought to be influenced by genetic factors (certain human leukocyte antigen genes). Treatment generally includes antibiotics to address the bacterial infection and other medications (i.e. pain medications) to relieve symptoms. Last updated: 10/6/2015

CDC:2 To receive email updates about this page, enter your email address:

Wikipedia:71 Lyme disease, also known as Lyme borreliosis, is an infectious disease caused by bacteria of the... more...

Related Diseases for Lyme Disease

About this section

Diseases related to Lyme Disease via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50)    (show all 348)
idRelated DiseaseScoreTop Affiliating Genes
1babesiosis31.6IL1B, IL6, TNF
2spotted fever30.2CD40LG, HSPD1
3lateral sclerosis29.4IL1B, IL6, TNF
4skin disease29.3IL1B, IL6, TNF
5tick-borne encephalitis29.1CD40LG, IL17A, TNF
6chorioretinitis28.8IL6, MMP9, TLR2, TNF
7cat-scratch disease28.6CD40LG, IL17A, IL1B, TLR2
8myelitis28.2CD40LG, IL17A, IL1B, MMP9, TNF
9rheumatoid arthritis26.7CD40LG, IL17A, IL1B, IL6, MMP9, TLR2
10lyme disease - neurological complications12.2
11human granulocytic anaplasmosis11.1
12powassan encephalitis11.1
13tick infestation11.1
14pars planitis10.8
15intermediate uveitis10.8
16autoimmune inner ear disease10.8
17complement factor h deficiency10.6CFH, CFHR1
18ornithosis10.5CD40LG, HSPD1
19rickettsialpox10.5CD40LG, TLR2
20norse10.5C3, CFH
21fallopian tube leiomyosarcoma10.5CD40LG, HSPD1
22hemolytic uremic syndrome, atypical 110.5CFH, CFHR1
23monoclonal paraproteinemia10.4CD40LG, IL6
24catsper1-related nonsyndromic male infertility10.4C3, CFHR1
25small intestinal vasoactive intestinal peptide producing tumor10.4CD40LG, HSPD1
26queensland tick typhus10.4HSPD1, IL6, TLR2
27atrial septal defect coronary sinus10.4IL1B, TLR2
28corneal deposit10.4IL1B, IL6
29tarsal tunnel syndrome10.4IL1B, IL6
30fallopian tube endometriosis10.3CFH, TNF
31disease_ontology10.3CD40LG, IL6
32melioidosis10.3IL6, TLR1, TLR2
33panner disease10.3IL6, TNF
34thyroid malformation10.3IL1B, TNF
35aortic arch interruption10.3IL6, TNF
36anti-basement membrane glomerulonephritis10.3C3, CFH, IL6
37cutaneous leishmaniasis10.3IL6, TNF
383-alpha hydroxyacyl-coa dehydrogenase deficiency10.3CFH, TLR2, TNF
39myxofibrosarcoma10.3C3, MMP9
40hypospadias, hypertelorism, upper lid coloboma, and mixed-type hearing loss10.3IL1B, TNF
41midline interhemispheric variant of holoprosencephaly10.2IL1B, IL6
42maligant granulosa cell tumor of ovary10.2IL6, TNF
43diabetic cataract10.2IL1B, MMP9
44hemometra10.2IL6, TNF
45mycobacterium fortuitum10.2TLR1, TLR2, TNF
46baetz-greenwalt syndrome10.2IL1B, TNF
47pulmonary hypertension10.2IL1B, TNF
48alkhurma hemorrhagic fever10.2CD40LG, TLR2, TNF
49conventional leiomyosarcoma10.2CD40LG, IL1B, IL6
50brucella abortus brucellosis10.2CD40LG, TNF

Graphical network of the top 20 diseases related to Lyme Disease:



Diseases related to lyme disease

Symptoms & Phenotypes for Lyme Disease

About this section

Symptoms:

 11 (show all 4)
  • fever
  • headache
  • fatigue
  • skin rash called erythema migrans

Human phenotypes related to Lyme Disease:

 64 54 (show all 30)
id Description HPO Frequency Orphanet Frequency HPO Source Accession
1 hypermelanotic macule64 hallmark (90%) HP:0001034
2 meningitis64 54 typical (50%) Frequent (79-30%) HP:0001287
3 arthritis64 54 typical (50%) Frequent (79-30%) HP:0001369
4 joint swelling64 54 typical (50%) Frequent (79-30%) HP:0001386
5 cranial nerve paralysis64 54 typical (50%) Frequent (79-30%) HP:0006824
6 photophobia64 54 occasional (7.5%) Occasional (29-5%) HP:0000613
7 skin rash64 occasional (7.5%) HP:0000988
8 muscle weakness64 54 occasional (7.5%) Occasional (29-5%) HP:0001324
9 nausea and vomiting64 54 occasional (7.5%) Occasional (29-5%) HP:0002017
10 migraine64 occasional (7.5%) HP:0002076
11 memory impairment64 54 occasional (7.5%) Occasional (29-5%) HP:0002354
12 encephalitis64 54 occasional (7.5%) Occasional (29-5%) HP:0002383
13 arthralgia64 54 occasional (7.5%) Occasional (29-5%) HP:0002829
14 myalgia64 54 occasional (7.5%) Occasional (29-5%) HP:0003326
15 paresthesia64 54 occasional (7.5%) Occasional (29-5%) HP:0003401
16 abnormality of temperature regulation64 occasional (7.5%) HP:0004370
17 aplasia/hypoplasia of the skin64 occasional (7.5%) HP:0008065
18 arrhythmia64 54 occasional (7.5%) Occasional (29-5%) HP:0011675
19 inflammatory abnormality of the eye64 occasional (7.5%) HP:0100533
20 amaurosis fugax64 54 occasional (7.5%) Occasional (29-5%) HP:0100576
21 insomnia64 54 occasional (7.5%) Occasional (29-5%) HP:0100785
22 uveitis54 Occasional (29-5%)
23 behavioral abnormality54 Occasional (29-5%)
24 atrioventricular block54 Occasional (29-5%)
25 fever54 Occasional (29-5%)
26 headache54 Occasional (29-5%)
27 dermal atrophy54 Occasional (29-5%)
28 peripheral neuropathy54 Occasional (29-5%)
29 fatigue54 Occasional (29-5%)
30 skin nodule54 Occasional (29-5%)

UMLS symptoms related to Lyme Disease:


pruritus

MGI Mouse Phenotypes related to Lyme Disease according to GeneCards Suite gene sharing:

41
idDescriptionMGI Source AccessionScoreTop Affiliating Genes
1MP:00053678.4C3, CD40LG, CFH, IL17A, IL6, MMP9
2MP:00053858.3C3, CD40LG, CFH, IL1B, IL6, MMP9
3MP:00053897.6C3, CD40LG, CLDN11, HSPD1, IL6, MMP9
4MP:00036317.3C3, CD40LG, CFH, CLDN11, HSPD1, IL1B
5MP:00053906.9C3, CD40LG, IL17A, IL1B, IL6, MMP9
6MP:00107686.8C3, CD40LG, CFH, HSPD1, IL17A, IL1B
7MP:00053976.5C3, CD40LG, CFH, IL17A, IL1B, IL6
8MP:00053876.5C3, CD40LG, CFH, IL17A, IL1B, IL6

Drugs & Therapeutics for Lyme Disease

About this section

Drugs for Lyme Disease (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50)    (show all 158)
idNameStatusPhaseClinical TrialsCas NumberPubChem Id
1
Doxycyclineapproved, investigational, vet_approvedPhase 4, Phase 3, Phase 2237564-25-054671203
Synonyms:
(2E,4S,4aR,5S,5aR,6R,12aS)-2-[amino(hydroxy)methylidene]-4-(dimethylamino)-5,10,11,12a-tetrahydroxy-6-methyl-4a,5,5a,6-tetrahydro-4H-tetracene-1,3,12-trione
(2Z)-2-[amino(hydroxy)methylidene]-4-(dimethylamino)-5,10,11,12a-tetrahydroxy-6-methyl-4a,5,5a,6-tetrahydro-4H-tetracene-1,3,12-trione
(2Z,4S,4aR,5S,5aR,6R)-2-[amino(hydroxy)methylidene]-4-(dimethylamino)-5,10,11,12a-tetrahydroxy-6-methyl-4a,5,5a,6-tetrahydro-4H-tetracene-1,3,12-trione
(2Z,4S,4aR,5S,5aR,6R,12aS)-2-[amino(hydroxy)methylidene]-4-(dimethylamino)-5,10,11,12a-tetrahydroxy-6-methyl-4a,5,5a,6-tetrahydro-4H-tetracene-1,3,12-trione
(4S,4aR,5S,5aR,6R,12aS)-4-(dimethylamino)-3,5,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2-carboxamide
10597-92-9
17086-28-1 (mono-hydrate)
2-Naphthacenecarboxamide, 4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,5,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-, (4S,4aR,5S,5aR,6R,12aS)
24390-14-5
41411-66-9 (6-epimer, mono-hydrochloride)
5-Hydroxy-alpha-6-deoxytetracycline
5-hydroxy-α-6-deoxytetracycline
564-25-0
6-Deoxyoxytetracycline
6-Deoxytetracycline
6-alpha-Deoxy-5-oxytetracycline
6-alpha-deoxy-5-oxytetracycline
69935-17-7 (mono-hydrochloride, di-hydrate)
6alpha-Deoxy-5-oxytetracycline
6alpha-deoxy-5-oxytetracycline
6α-deoxy-5-oxytetracycline
7164-70-7
7264-10-0
94088-85-4 (calcium salt (1:2))
AB08 (*Fosfatex)
AC1NQXW7
AC1NS4CW
AC1NUYS8
AC1O8PYM
Alti-Doxycycline
Anhydrous doxycycline
Apo-Doxy
Atridox
Azudoxat
BCBcMAP01_000024
BIDD:GT0146
BMY-28689
BPBio1_000951
BSPBio_000863
BSPBio_001936
BU-3839T
C06973
CHEBI:50845
CHEMBL1433
CID5281011
CID5353597
CID5463943
CID6713981
CPD001550033
D07876
DB00254
DMSC (*Fosfatex)
DOXCYCLINE ANHYDROUS
DOXY
DOXYCYCLINE CALCIUM
DOXYCYCLINE MONOHYDRATE
Deoxymykoin
DivK1c_000345
Dossiciclina
Dossiciclina [DCIT]
Doxcycline anhydrous
Doxiciclina
Doxiciclina [INN-Spanish]
Doxiciclina [Italian]
Doxitard
Doxivetin
Doxy-Caps
Doxy-Puren
Doxy-Tabs
Doxycen
Doxychel
Doxychel (TN)
Doxycin
Doxycyclin
Doxycycline (200mg/day) or Placebo
 
Doxycycline (INN)
Doxycycline (TN)
Doxycycline (anhydrous)
Doxycycline (internal use)
Doxycycline Hyclate
Doxycycline Monohydrate
Doxycycline anhydrous
Doxycycline hyclate
Doxycycline-Chinoin
Doxycyclinum
Doxycyclinum [INN-Latin]
Doxysol
Doxytec
Doxytetracycline
EINECS 209-271-1
GS-3065 (*monohydrate)
HMS2090E06
HSDB 3071
Hydramycin
IDI1_000345
Investin
Jenacyclin
KBio1_000345
KBio2_001287
KBio2_003855
KBio2_006423
KBio3_001156
KBioGR_001133
KBioSS_001287
LS-187766
LS-93868
Liviatin
Lopac0_000405
MolPort-002-507-423
Monodox
Monodox (*monohydrate)
NCGC00161602-01
NCGC00161602-03
NCGC00161602-04
NCGC00167961-01
NCGC00179395-01
NINDS_000345
NSC633557
Novo-Doxylin
Nu-Doxycycline
Oracea
Prestwick0_000852
Prestwick1_000852
Prestwick2_000852
Prestwick3_000852
Ronaxan
SAM002589932
SMP1_000107
SPBio_000246
SPBio_002784
STOCK1N-34341
Spanor
Spectrum2_000143
Spectrum3_000408
Spectrum4_000527
Spectrum5_000947
Spectrum_000807
Supracyclin
UNII-334895S862
UPCMLD-DP021
UPCMLD-DP021:001
Vibra-tabs
Vibramycin
Vibramycin (*monohydrate)
Vibramycin Novum
Vibramycine
Vibravenos
Vivox (*Hyclate)
alpha-6-Deoxy-5-hydroxytetracycline
alpha-6-Deoxyoxytetracycline
alpha-Doxycycline
doxycycline
2
CeftriaxoneapprovedPhase 4, Phase 3, Phase 1, Phase 211473384-59-55479530, 5361919
Synonyms:
(6R,7R)-7-(2-(2-Amino-4-thiazolyl)glyoxylamido)-8-oxo-3-(((1,2,5,6-tetrahydro-2-methyl-5,6-dioxo-as-triazin-3-yl)thio)methyl)-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7(sup 2)-(Z)-(O-methyloxime), sesquaterhydrate
(6R,7R)-7-({(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-[(methyloxy)imino]acetyl}amino)-3-{[(6-hydroxy-2-methyl-5-oxo-2,5-dihydro-1,2,4-triazin-3-yl)thio]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
(6R,7R)-7-[[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-methoxyiminoacetyl]amino]-3-[(2-methyl-5,6-dioxo-1H-1,2,4-triazin-3-yl)sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
(6R,7R)-7-{[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetyl]amino}-3-{[(2-methyl-5,6-dioxo-1,2,5,6-tetrahydro-1,2,4-triazin-3-yl)sulfanyl]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
104376-79-6
104376-79-6 (di-hydrochloride salt)
73384-59-5
74578-69-1 (di-hydrochloride salt, hemiheptahydrate)
7beta-{[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetyl]amino}-3-{[(2-methyl-5,6-dioxo-1,2,5,6-tetrahydro-1,2,4-triazin-3-yl)sulfanyl]methyl}-3,4-didehydrocepham-4-carboxylic acid
AC-1592
AC1NUIFE
Biotrakson
C06683
C18H18N8O7S3
CEFTRIAXONE SODIUM
CHEBI:29007
CHEMBL161
CID5479530
CTRX
Cefatriaxone
Ceftriaxon
Ceftriaxona
Ceftriaxona [INN-Spanish]
 
Ceftriaxone (INN)
Ceftriaxone (TN)
Ceftriaxone [USAN:JAN]
Ceftriaxone intravenous
Ceftriaxone, Disodium Salt
Ceftriaxone, Disodium Salt, Hemiheptahydrate
Ceftriaxonum
Ceftriaxonum [INN-Latin]
Ceftriazone
D07659
DB01212
DRG-0071
EINECS 277-405-6
LS-150031
Longacef
Longaceph
MolPort-005-933-495
Ro 139904
Ro-13-9904
Ro13-9904
Rocefin
Rocephin
Rocephine
UNII-75J73V1629
ceftriaxone
3
AzithromycinapprovedPhase 4, Phase 1, Phase 233383905-01-555185, 53477736, 447043
Synonyms:
(2R,3S,4R,5R,8R,10R,11R,12S,13S,14R)-11-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-2-ethyl-3,4,10-trihydroxy-13-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy-3,5,6,8,10,12,14-heptamethyl-1-oxa-6-azacyclopentadecan-15-one
(2R,3S,4R,5R,8R,10R,11R,12S,13S,14R)-13-((2,6-Dideoxy-3-C-methyl-3-O-methyl-alpha-L-ribo-hexopyranosyl)oxy)-2-ethyl-3,4,10-trihydroxy-3,5,6,8,10,12,14-heptamethyl-11-((3,4,6-trideoxy-3-(dimethylamino)-beta-D-xylo-hexopyranosyl)oxy)-1-oxa-6-azacyclopentadecan-15-one
(2R,3S,4R,5R,8R,10R,11R,12S,13S,14R)-2-ethyl-3,4,10-trihydroxy-3,5,6,8,10,12,14-heptamethyl-15-oxo-11-{[3,4,6-trideoxy-3-(dimethylamino)-b-D-xylo-hexopyranosyl]oxy}-1-oxa-6-azacyclopentadecan-13-yl 2,6-dideoxy-3-C-methyl-3-O-methyl-a-L-ribo-hexopyranoside
(2R,3S,4R,5R,8R,10R,11R,12S,13S,14R)-2-ethyl-3,4,10-trihydroxy-3,5,6,8,10,12,14-heptamethyl-15-oxo-11-{[3,4,6-trideoxy-3-(dimethylamino)-beta-D-xylo-hexopyranosyl]oxy}-1-oxa-6-azacyclopentadecan-13-yl 2,6-dideoxy-3-C-methyl-3-O-methyl-alpha-L-ribo-hexopyranoside
(2R,3S,4R,5R,8R,10R,11R,12S,13S,14R)13-((2,6-Dideoxy-3-C-methyl-3-O-methyl-alpha-L-ribo-hexopyranosyl)oxy)-2-ethyl-3,4,10-trihydroxy-3,5,6,8,10,12,14-heptamethyl-11-((3,4,6-trideoxy-3-(dimethylamino)-beta-D-xylo-hexopyranosyl)oxy)-1-oxa-6-azacyclopentadecan-15-one
1-Oxa-6-azacyclopentadecan-15-one, 13-((2,6-dideoxy-3-C-methyl-3-O-methyl-alpha-L-ribo-hexopyranosyl)oxy)-2-ethyl-3,4,10-trihydroxy-3,5,6,8,10,12,14-heptamethyl-11-((3,4,6-trideoxy-3-(dimethylamino)-beta-D-xylo-hexopyranosyl)oxy)-,(2R-(2R*,3S*
121470-24-4
75199_FLUKA
83905-01-5
9-Deoxo-9a-aza-9a-methyl-9a-homoerythromycin A
AC-16014
AC1L9KEG
Aritromicina
Azasite
Azenil
Azifast
Azigram
Azimakrol
Azithramycine
Azithromycin
Azithromycin & Tumor Necrosis Factor
Azithromycin (AIDS Initiative)
Azithromycin (anhydrous)
Azithromycin Dihydrate
Azithromycin Monohydrate
Azithromycin Sterile
Azithromycin dihydrate
Azithromycin plus Tumor Necrosis Factor
Azithromycine
Azithromycine [French]
Azithromycinum
Azithromycinum [Latin]
Azitrocin
Azitromax
Azitromicina
Azitromicina [Spanish]
Azitromin
Azythromycin
BIDD:GT0792
BRN 5387583
BSPBio_002285
Bio-0676
C38H72N2O12
CCRIS 1961
CHEBI:2955
CHEMBL529
CID447043
CP-62993
CP62,993
CPD000471864
DCH3
DRG-0104
 
DivK1c_000233
HMS1922G12
HMS2094M11
HMS500L15
HSDB 7205
Hemomycin
IDI1_000233
KBio1_000233
KBio2_000787
KBio2_003355
KBio2_005923
KBio3_001505
KBioGR_000731
KBioSS_000787
LS-1834
MLS001055353
MLS001066331
MLS001201763
MLS001304005
MLS001332499
MLS001332500
Misultina
MolPort-002-507-426
N,N-Dimethyl-4-amino-benzaldehyde
NCGC00090753-01
NCGC00090753-02
NINDS_000233
NSC643732
SAM002589961
SMR000471864
SPBio_001544
SPECTRUM1503679
Spectrum2_001582
Spectrum3_000653
Spectrum4_000186
Spectrum5_001867
Spectrum_000307
Sumamed
Tromix
UNII-JTE4MNN1MD
XZ-450
Z-Pak
ZIT
Zentavion
Zithromac
Zithromax
Zithromax IV
Zithromycin
Zitromax
Zitromax Avium 600
Zmas
Zmax
azithromycin
4
ClarithromycinapprovedPhase 427181103-11-984029
Synonyms:
(14R)-14-Hydroxyclarithromycin
116836-41-0
6-O-Methylerythromycin
6-O-Methylerythromycin a
6-O-methyl erythromycin
81103-11-9
A-56268
AC-6813
AC1L1HJO
AC1L36NJ
AC1NFSZE
AC1NR4MY
AC1NSJWH
AC1O52DV
AC1Q6O1T
ANX-015
Abbotic
Abbott-56268
Adel
Astromen
BB_NC-1450
BIDD:GT0200
BSPBio_003453
Biaxin
Biaxin (TN)
Biaxin HP
Biaxin XL
Biaxin filmtab
Biaxin xl filmtab
Bicrolid
Bio-0020
C06912
C2220
C30H54O11.C9H19NO2
CCRIS 8833
CHEBI:136451
CHEBI:3732
CHEMBL143
CHEMBL1741
CID10147055
CID10328822
CID11814635
CID11828745
CID11969952
CID4663848
CID489010
CID5284534
CID5311050
CID54688
CID6426662
CID84029
CID9810688
CID9811194
CLA
CLARITHROMYCIN
CLM & IL-12
CPD000466382
CRL-1605 & Clarithromycin
CTY
Clacine
Clambiotic
Claribid
Claricide
Clarith
Clarithromycin & Interleukin-12
Clarithromycin (JP15/USP/INN)
Clarithromycin [USAN:INN:BAN:JAN]
Clarithromycin extended release
Clarithromycin suspension or tablets
Clarithromycina
Clarithromycine
Clarithromycine [INN-French]
 
Clarithromycinum
Clarithromycinum [INN-Latin]
Claritromicina
Claritromicina [INN-Spanish]
Clathromycin
Cyllid
Cyllind
D00276
DRG-0099
DivK1c_006655
HMS1922H09
HMS2051G18
HMS2090O11
HMS2094M05
Helas
Heliclar
I05-0074
KBio1_001599
KBio2_000509
KBio2_003077
KBio2_005645
KBio3_002673
KBioGR_001218
KBioSS_000509
Klacid
Klaciped
Klaricid
Klaricid H.P
Klaricid H.P.
Klaricid Pediatric
Klaricid XL
Klarid
Klarin
Klax
Kofron
LMPK04000014
LS-1812
Lactoferrin B & Clarithromycin
Lactoferrin H & Clarithromycin
MLS000759516
MLS001201751
MLS001424066
Mabicrol
Macladin
Maclar
Mavid
MolPort-002-507-425
MolPort-003-845-969
MolPort-005-910-192
MolPort-005-934-146
NCGC00178054-01
NSC643733
Naxy
O(6)-methylerythromycin
SAM001246748
SDP-015
SMR000466382
SPBio_001855
SPECTRUM1504231
STK801952
SpecPlus_000559
Spectrum2_001668
Spectrum3_001667
Spectrum4_000629
Spectrum5_001729
Spectrum_000089
TE-031
TE031
UNII-H1250JIK0A
Veclam
Zeclar
clarithromycin
clarithromycina
hydro-2H-pyran-2-yl]oxy}-7-methoxy-3,5,7,9,11,13-hexame
5
CefuroximeapprovedPhase 45555268-75-25361202, 5479529
Synonyms:
(6R,7R)-3-(carbamoyloxymethyl)-7-[[(2Z)-2-(furan-2-yl)-2-methoxyiminoacetyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
(6R,7R)-3-[(Carbamoyloxy)methyl]-7-{[(2Z)-2-furan-2-yl-2-(methoxyimino)acetyl]amino}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
(6R,7R)-3-[(carbamoyloxy)methyl]-7-[(2Z)-2-(furan-2-yl)-2-(methoxyimino)acetamido]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
(6R,7R)-3-[(carbamoyloxy)methyl]-7-{[(2Z)-2-furan-2-yl-2-(methoxyimino)acetyl]amino}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
(6R,7R)-7-(2-(2-Furyl)glyoxylamido)-3-(hydroxymethyl)-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid 7(sup 2)-(Z)-(O-methyloxime) carbamate (ester)
153012-39-6
3-[(carbamoyloxy)methyl]-7beta-[(2Z)-2-(furan-2-yl)-2-(methoxyimino)acetamido]-3,4-didehydrocepham-4-carboxylic acid
55268-75-2
56238-63-2
AC-15028
AC-4539
AC1NUIFB
AC1Q41FS
Anaptivan
BIDD:GT0619
BPBio1_001033
BRD-K02733959-236-02-8
BRN 5783190
BSPBio_000939
Biociclin
Biofuroksym
Bioxima
C06894
C08108
C16H15N4O8S.Na
C16H16N4O8S
C4417_FLUKA
C4417_SIGMA
CEFUROXIME AND DEXTROSE IN DUPLEX CONTAINER
CEFUROXIME SODIUM
CHEBI:3515
CHEMBL1436
CID5479529
CID6523269
CPD0-2069
CXM
Cefofix
Cefumax
Cefurex
Cefuril
Cefuroxim
Cefuroxim AJ
Cefuroxim Fresenius
Cefuroxim Genericsn
Cefuroxim Hexal
Cefuroxim Lilly
Cefuroxim MN
Cefuroxim Norcox
Cefuroxim Norcox [inj.]
Cefuroxim curasan
Cefuroxima Fabra
Cefuroxima Richet
Cefuroxime
Cefuroxime (TN)
 
Cefuroxime (USAN/INN)
Cefuroxime [USAN:BAN:INN]
Cefuroxime [USAN:INN:BAN]
Cefuroxime for Injection and Dextrose for Injection in Duplex Container
Cefuroxime sodium (JP15/USP)
Cefuroxime sodium [USAN:BAN:JAN]
Cefuroxime sodium salt
Cefuroximine
Cefuroximo
Cefuroximo [INN-Spanish]
Cefuroximum
Cefuroximum [INN-Latin]
Cephuroxime
Cetroxil
Cetroxil [inj.]
Colifossim
Curocef
Curoxim
Curoxima
Curoxime
D00262
D00915
EINECS 259-560-1
EINECS 260-073-1
Froxal
Froxal [inj.]
Furoxil
KEFUROX IN PLASTIC CONTAINER
KS-1040
Kesint
Ketocef
LS-149936
LS-2226
Lifurox
Medoxim
MolPort-002-885-814
MolPort-005-938-003
Prestwick3_000720
Sharox
Sharox [inj.]
Sodium (6R,7R)-7-(2-(2-furyl)glyoxylamido)-3-(hydroxymethyl)-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylate, 7(sup 2)-(Z)-(O-methyloxime), carbamate (ester)
Sodium (6R-(6alpha,7beta(Z)))-3-(((aminocarbonyl)oxy)methyl)-7-(2-furyl(methoxyimino)acetamido)-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylate
Sodium cefuroxime
Spectrazolr
UNII-O1R9FJ93ED
UNII-R8A7M9MY61
Ultroxim
ZINACEF IN PLASTIC CONTAINER
Zinacef
Zinacef (TN)
Zinacef Danmark
Zinacef danmark
Zinnat [inj.]
cefuroxime
cefuroxime na
cefuroximesodium
6
Erythromycinapproved, vet_approvedPhase 495114-07-812560
Synonyms:
(3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-6-{[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyltetrahydro-2H-pyran-2-yl]oxy}-14-ethyl-7,12,13-trihydroxy-4-{[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyltetrahydro-2H-pyran-2-yl]oxy}-3,5,7,9,11,13-hexamethyloxacyclotetradecane-2,10-dione
,10-dione
114-07-8
3''-O-demethylerythromycin
374700-25-1
45673_FLUKA
45674_FLUKA
79235-06-6
82343-12-2
A/T/S
AC-12744
AC1L1FIQ
AC1L1QK7
AC1L1ZUR
AC1O8PVA
AC1Q2UA1
AC1Q6O1S
AI3-50138
AR-1A4414
AR-1H0723
Abboticin
Abomacetin
Acneryne
Acnesol
Ak-Mycin
Ak-mycin
Akne Cordes Losung
Akne-Mycin
Akne-mycin (TN)
Aknederm Ery Gel
Aknemycin
Aknin
AustriaS
BB_NC-1332
BIDD:GT0017
BPBio1_000312
BSPBio_000282
BSPBio_002480
Benzamycin
Benzamycin Pak
Bristamycin
C-Solve-2
C01912
C37H67NO13
CCRIS 9078
CHEBI:42355
CHEMBL532
CID12560
CID3255
CID6713919
CID8233
D00140
DB00199
Del-Mycin
Derimer
Deripil
DivK1c_000294
DivK1c_000397
DivK1c_000702
Dotycin
Dumotrycin
E- mycin, Erycin, Robimysin
E-Base
E-Base (base)
E-Glades
E-Mycin
E-Mycin (base)
E-Solve 2
E0751
E0774_SIAL
E5389_SIGMA
E6376_SIAL
E7904_SIGMA
EINECS 204-040-1
EM
EMU
ERY
ERYC
ERYC (base)
ERYTHROMYCIN STEARATE
ETS
Emgel
Emu-V
Emu-Ve
Emuvin
Emycin
Endoeritrin
Erecin
Erimycin-T
Erisone
Eritomicina
Eritrocina
Eritromicina
Eritromicina [INN-Spanish]
Ermycin
Eros
Ery-B
Ery-Diolan
Ery-Sol
Ery-Tab
Ery-Tab (base)
Ery-maxin
Eryacne
Eryacnen
Eryc
Eryc (TN)
Eryc 125
Eryc Sprinkles
Eryc-125
Eryc-250
Erycen
Erycette
Erycin
Erycinum
Eryderm
Erydermer
Erygel
Erygel (TN)
Eryhexal
Erymax
Erymed
Erypar
Erysafe
Erytab
Erythra-Derm
Erythro
Erythro-Statin
Erythro-Teva
Erythrocin
Erythrocin Stearate
Erythroderm
Erythrogran
Erythroguent
Erythromast 36
Erythromid
Erythromycin
Erythromycin & VRC3375
Erythromycin (JP15/USP/INN)
 
Erythromycin A
Erythromycin A, T-Stat, Pantomicina, HSDB 3074, Erytab, DRG-0279
Erythromycin B
Erythromycin C
Erythromycin Lactate
Erythromycin Ointment
Erythromycin Stearate
Erythromycin [INN:BAN:JAN]
Erythromycin base
Erythromycin estolate
Erythromycin ethylsuccinate
Erythromycin glucoheptonate
Erythromycin intravenous
Erythromycin lactobionate
Erythromycin oxime
Erythromycin sodium lauryl sulfate
Erythromycin, compd. with monododecyl sulfate, sodium salt
Erythromycine
Erythromycine [INN-French]
Erythromycinum
Erythromycinum [INN-Latin]
Erytop
Erytrociclin
Ethril 250
HMS1568O04
HMS1920M04
HMS2091D05
HMS500O16
HSDB 3074
I06-0245
IDI1_000294
IDI1_000397
IDI1_000702
Ilocaps
Ilosone
Ilosone (estolate)
Iloticina
Ilotycin
Ilotycin Gluceptate
Ilotycin T.S
Ilotycin T.S.
Inderm
Inderm Gel
IndermRetcin
KBio1_000294
KBio1_000397
KBio1_000702
KBio2_000555
KBio2_001139
KBio2_003123
KBio2_003707
KBio2_005691
KBio2_006275
KBioGR_001175
KBioSS_000555
KBioSS_001139
KST-1A8261
Kesso-Mycin
LMPK04000006
LS-187077
LS-64648
Latotryd
Lederpax
MLS001066618
Mephamycin
Mercina
MolPort-000-772-161
MolPort-002-507-378
MolPort-003-933-429
N-Methylerythromycin A
NCGC00179619-01
NCI-C55674
NINDS_000294
NINDS_000397
NINDS_000702
NSC 55929
NSC55929
Oftalmolosa Cusi Eritromicina
Oftamolets
PCE Dispertab (base)
Paediathrocin
Pantoderm
Pantodrin
Pantomicina
Pce
Pce (TN)
Pfizer-e
Pharyngocin
Prestwick0_000151
Prestwick1_000151
Prestwick2_000151
Prestwick3_000151
Prestwick_205
Primacine
Propiocine
Proterytrin
R-P Mycin
Retcin
Robimycin
Romycin
SBB057401
SMP1_000119
SMR000544946
SPBio_000778
SPBio_001226
SPBio_002221
SPECTRUM1500280
STK249736
Sans-acne
Sansac
Serp-AFD
Skid Gel E
Spectrum2_000759
Spectrum2_001263
Spectrum4_000538
Spectrum5_001596
Spectrum_000115
Spectrum_000659
Staticin
Staticin (TN)
Stiemicyn
Stiemycin
Sulfuric acid, monododecyl ester, sodium salt, compd. with erythromycin
T-Stat
T-stat (TN)
Taimoxin-F
Theramycin Z
Tiloryth
Tiprocin
Torlamicina
UNII-63937KV33D
Udima Ery Gel
Wemid
Wyamycin S
adecane-2,10-dione (non-preferred name)
bmse000664
erythro
erythromycin
nchembio.285-comp13
érythromycine
7
HydroxychloroquineapprovedPhase 4146118-42-33652
Synonyms:
(+-)-Hydroxychloroquine
(±)-hydroxychloroquine
118-42-3
2-((4-((7-Chloro-4-quinolyl)amino)pentyl)ethylamino)ethanol
2-((4-((7-chloro-4-Quinolyl)amino)pentyl)ethylamino)ethanol
2-(N-(4-(7-Chlor-4-chinolylamino)-4-methylbutyl)ethylamino)ethanol
2-[4-[(7-chloroquinolin-4-yl)amino]pentyl-ethylamino]ethanol
2-[{4-[(7-chloroquinolin-4-yl)amino]pentyl}(ethyl)amino]ethanol
5-22-10-00280 (Beilstein Handbook Reference)
7-Chloro-4-(4-(N-ethyl-N-beta-hydroxyethylamino)-1-methylbutylamino)quinoline
7-Chloro-4-(4-(ethyl(2-hydroxyethyl)amino)-1-methylbutylamino)quinoline
7-Chloro-4-(5-(N-ethyl-N-2-hydroxyethylamino)-2-pentyl)aminoquinoline
7-chloro-4-(4-(Ethyl(2-hydroxyethyl)amino)-1-methylbutylamino)quinoline
7-chloro-4-(4-(N-Ethyl-N-beta-hydroxyethylamino)-1-methylbutylamino)quinoline
7-chloro-4-[4-(N-Ethyl-N-beta-hydroxyethylamino)-1-methylbutylamino]quinoline
7-chloro-4-[5-(N-Ethyl-N-2-hydroxyethylamino)-2-pentyl]aminoquinoline
747-36-4 (sulfate (1:1) salt)
AC1L1GEW
BRN 0253894
C07043
C18H26ClN3O
CHEMBL1535
CID3652
D08050
DB01611
DivK1c_000942
EINECS 204-249-8
Gen-Hydroxychloroquine 200mg Tablets
HCQ
HMS502P04
Hidroxicloroquina
 
Hidroxicloroquina [INN-Spanish]
Hydroxychlorochin
Hydroxychloroguine
Hydroxychloroquine (INN)
Hydroxychloroquine Sulfate (1:1) Salt
Hydroxychloroquine [INN:BAN]
Hydroxychloroquinum
Hydroxychloroquinum [INN-Latin]
IDI1_000942
Idrossiclorochina
Idrossiclorochina [DCIT]
KBio1_000942
LS-66614
MolPort-003-847-792
NCGC00159483-02
NINDS_000942
NSC4375
Oxichlorochine
Oxichlorochinum
Oxichloroquine
Oxychlorochin
Oxychloroquine
PlaqueN/A
Polirreumin
Polirreumin (TN)
Quensyl
SPBio_001116
ST072188
Spectrum2_001238
Spectrum5_001697
UNII-4QWG6N8QKH
WIN 1258
hydroxychloroquine
8
Penicillin Vapproved, vet_approvedPhase 41787-08-16869
Synonyms:
(2S,5R,6R)-3,3-DIMETHYL-7-OXO-6-(2-PHENOXYACETAMIDO)-4-THIA-1- AZABICYCLO(3.2.0)HEPTANE-2-CARBOXYLIC ACID
(2S,5R,6R)-3,3-Dimethyl-7-oxo-6-(2-phenoxyacetamido)-4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid
(2S,5R,6R)-3,3-Dimethyl-7-oxo-6-[(phenoxyacetyl)amino]-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid
(2S,5R,6R)-3,3-dimethyl-7-oxo-6-[(2-phenoxyacetyl)amino]-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid
(2S,5R,6R)-3,3-dimethyl-7-oxo-6-[(phenoxyacetyl)amino]-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid
(2S,5R,6R)-3,3-dimethyl-7-oxo-6-{[(phenyloxy)acetyl]amino}-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid
1098-87-9 (mono-hydrochloride salt)
132-98-9
132-98-9 (mono-potassium salt)
147-48-8 (mono-hydrochloride salt)
2,2-dimethyl-6beta-[(phenoxyacetyl)amino]penam-3alpha-carbonyl
2,2-dimethyl-6beta-[(phenoxyacetyl)amino]penam-3alpha-carboxylic acid
3,3-Dimethyl-7-oxo-6-((phenyloxyacetyl)amino)-4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid
3,3-dimethyl-6beta-[(phenoxyacetyl)amino]penam-2alpha-carboxylic acid (PIN)
4-27-00-05884 (Beilstein Handbook Reference)
6-Phenoxyacetamidopenicillanic acid
6-phenoxyacetamidopenicillanic acid
87-08-1
AB00514745
AC1L1NHG
AC1Q5QX3
AR-1H6492
Acipen V
Apocillin
Apopen
BRD-K43966364-237-02-2
BRN 0096259
BSPBio_002185
Beepen-VK
Beromycin
Beromycin, Penicillin
Berromycin, Penicillin
Betapen-VK
Bio-0630
C08126
C16H18N2O5S
CCRIS 752
CHEBI:27446
CHEBI:53706
CHEMBL615
CID6869
Calcipen
Compocillin V
Crystapen V
D05411
DB00417
DB08415
Distaquaine V
DivK1c_000779
EINECS 201-722-0
Eskacillian V
Eskacillin V
Fenacilin
Fenospen
Fenossimetilpenicillina
Fenossimetilpenicillina [DCIT]
Fenossimetilpenicillina [Dcit]
Fenoximetilpenicilina
Fenoximetilpenicilina [INN-Spanish]
Fenoxymethylpenicillin
Fenoxypen
HSDB 6314
IDI1_000779
KBio1_000779
KBio2_001487
KBio2_004055
KBio2_006623
KBio3_001685
KBioGR_000944
KBioSS_001487
 
LS-1861
MLS001304105
Meropenin
MolPort-002-515-462
NCGC00159342-02
NINDS_000779
Oracillin
Oratren
Ospen
P-Mega-Tablinen
PNV
PV
PVA
Pen-Oral
Pen-V
Pen-vee
Penapar-Vk
Penicillin Phenoxymethyl
Penicillin V
Penicillin V (USP)
Penicillin V Potassium
Penicillin V [USAN]
Penicillin phenoxymethyl
Penicillin, Phenoxymethyl
Penicillin-Vk
Phenocillin
Phenomycilline
Phenopenicillin
Phenoximethylpenicillinum
Phenoxomethylpenicillin
Phenoxymethyl Penicillin
Phenoxymethyl penicillin
Phenoxymethylenepenicillinic Acid
Phenoxymethylenepenicillinic acid
Phenoxymethylpenicillin
Phenoxymethylpenicillin (INN)
Phenoxymethylpenicillin Potassium
Phenoxymethylpenicilline
Phenoxymethylpenicilline [INN-French]
Phenoxymethylpenicillinic Acid
Phenoxymethylpenicillinic Acid Potassium Salt
Phenoxymethylpenicillinic acid potassium salt
Phenoxymethylpenicillinum
Phenoxymethylpenicillinum [INN-Latin]
Phénoxyméthylpénicilline
Robicillin
Rocilin
SMR000539431
SPBio_000389
Spectrum2_000495
Spectrum3_000543
Spectrum4_000472
Spectrum5_001409
Spectrum_001007
Stabicillin
UNII-Z61I075U2W
V-Cil
V-Cillin
V-Cillin (TN)
V-Cillin K
V-Cylina
V-Cyline
V-Tablopen
Vebecillin
Vegacillin
acipen-v
penicillin v
phenoxomethylpenicillanyl
phenoxomethylpenicillin
phenoxymethylpenicillanyl
phenoxymethylpenicillinic acid
9
Amoxicillinapproved, vet_approvedPhase 444126787-78-033613, 2171
Synonyms:
(-)-6-(2-Amino-2-(P-hydroxyphenyl)acetamido)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo-(3.2.0)heptane-2-carboxylic acid
(2S,5R,6R)-6-[[(2R)-2-amino-2-(4-hydroxyphenyl)acetyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid
(2S,5R,6R)-6-{[(2R)-2-amino-2-(4-hydroxyphenyl)acetyl]amino}-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid
26787-78-0
33911-69-2
34642-77-8 (mono-hydrochloride salt)
4-Thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, 6-(2-amino-2-(p-hydroxyphenyl)acetamido)-3,3-dimethyl-7-oxo-, D- (8CI)
6-(D-(-)-alpha-Amino-p-hydroxyphenylacetamido)penicillanic acid
6-(D-(-)-p-Hydroxy-alpha-aminobenzyl)penicillin
6-(P-Hydroxy-alpha-aminophenylacetamido)penicillanic acid
6-(a-Amino-4-hydroxyphenylacetamido)penicillanic acid
6-(p-Hydroxy-alpha-aminophenylacetamido)penicillanic acid
6-(p-hydroxy-α-aminophenylacetamido)penicillanic acid
6-[[Amino(4-hydroxyphenyl)acetyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid, 9CI
61336-70-7 (TRIHYDRATE)
6beta-[(2R)-2-amino-2-(4-hydroxyphenyl)acetamido]-2,2-dimethylpenam-3alpha-carbonyl
6beta-[(2R)-2-amino-2-(4-hydroxyphenyl)acetamido]-2,2-dimethylpenam-3alpha-carboxylic acid
71447-36-4
81030-75-3
AC-12263
AC1L1PY2
AMC
AMOXICILLIN CRYSTALLINE
AMOXICILLIN PEDIATRIC
AMPC
AUGMENTIN '125'
AUGMENTIN '200'
AUGMENTIN '250'
AUGMENTIN '400'
AUGMENTIN '500'
AUGMENTIN '875'
AUGMENTIN ES-600
AX
Actimoxi
Almodan
Ambap26787-78-0
Amix
Amoclen
Amolin
Amopen
Amopenixin
Amoram
Amox
Amox 250 Cap 250mg
Amox 500 Cap 500mg
Amox S 125 Sus 125mg/5ml
Amox S 250 Sus 250mg/5ml
Amoxi
Amoxi-Mast
Amoxi-mast
Amoxibiotic
Amoxicaps
Amoxicilina
Amoxicilina [INN-Spanish]
Amoxicillin (INN)
Amoxicillin (TN)
Amoxicillin (anhydrous)
Amoxicillin (inn)
Amoxicillin Trihydrate
Amoxicillin and clavulanate potassium
Amoxicillin anhydrous
Amoxicillin pediatric
Amoxicillin trihydrate
Amoxicillin(usan)
Amoxicilline
Amoxicilline [INN-French]
Amoxicilline [INN]
Amoxicilline [inn]
Amoxicillinum
Amoxicillinum [INN-Latin]
Amoxid
Amoxiden
Amoxil
Amoxivet
Amoxycillin
Amoxycillin Trihydrate
Amoxycillin trihydrate
Amoxycillin, BAN
Amoxymed
Amrit
Anemolin
Apo-Amoxi
Apo-Amoxi Cap 250mg
Apo-Amoxi Cap 500mg
Apo-Amoxi Pwr for Susp 125mg/5ml
Apo-Amoxi Pwr for Susp 250mg/5ml
Apo-amoxi
Apo-amoxi sugar free
Aspenil
BL-P 1410
BLP 1410
BPBio1_000499
BRD-K55044200-001-03-9
BRL 2333
BRL-2333
BSPBio_000453
 
Biomox
Bristamox
C06827
CHEBI:2676
CHEBI:53712
CHEMBL1082
CID33613
CPD000058707
Cemoxin
Clamoxyl
Clamoxyl (SKB)
D-(-)-alpha-Amino-p-hydroxybenzyl penicillin
D-(-)-alpha-Amino-p-hydroxybenzylpenicillin
D-(alpha-Amino-p-hydroxybenzyl)penicillin
D-2-Amino-2-(4-hydroxyphenyl)acetamidopenicillanic acid
D-Amoxicillin
D07452
DB01060
Delacillin
DisperMox
Dispermox
EINECS 248-003-8
Efpenix
Flemoxin
Galenamox
Gen-Amoxicillin 250mg
Gen-Amoxicillin 500mg
HMS1569G15
HSDB 3204
Hiconcil
Histocillin
Hydroxyampicillin
Ibiamox
Imacillin
LS-149721
Lamoxy
Larotid
MLS000028632
MLS002222248
Metafarma capsules
Metifarma capsules
MolPort-003-981-182
MolPort-005-933-687
Moxacin
Moxal
Moxatag
NCGC00179554-01
NSC 277174
NSC277174
Novamoxin Cap 250mg
Novamoxin Cap 500mg
Novamoxin Sus 125mg/5ml
Novamoxin Sus 250mg/5ml
Nu-Amoxi Cap 250mg
Nu-Amoxi Cap 500mg
Nu-Amoxi Sus 125/5ml
Nu-Amoxi Sus 250mg/5ml
Ospamox
P-Hydroxyampicillin
PHL-amoxicillin
PMS-amoxicillin
Pamoxicillin
Piramox
Polymox
Prestwick0_000357
Prestwick1_000357
Prestwick2_000357
Prestwick3_000357
Prestwick_713
Prevpac
Pro Amox Pwr for Oral Susp 125mg/5ml
Pro Amox-250 Cap 250mg
Pro Amox-500 Cap 500mg
Pro-Amox-250 Orl Sus 250mg/5ml
R-Hydroxyampicillin
Rimoxallin
Ro 10-8756
Robamox
SAM002264592
SMR000058707
SPBio_002374
Sauracillin
Sawamox PM
Sumox
Tolodina
Trimox
Unicillin
Utimox
Vetramox
Wymox
Zimox
alpha-Amino-p-hydroxybenzylpenicillin
alpha-amino-P-Hydroxybenzylpenicillin
amoxicillanyl
amoxicillin
p-Hydroxyampicillin
α-amino-p-hydroxybenzylpenicillin
10
Prednisoloneapproved, vet_approvedPhase 4115350-24-85755
Synonyms:
(11beta)-11,17,21-Trihydroxypregna-1,4-diene-3,20-dione
.DELTA.1-Cortisol
.DELTA.1-Dehydrocortisol
.DELTA.1-Dehydrohydrocortisone
.DELTA.1-Hydrocortisone
.delta.-Cortef
.delta.-Stab
1,2-Dehydrohydrocortisone
1,4-Pregnadiene-11beta,17alpha,21-triol-3,20-dione
1,4-Pregnadiene-3,20-dione-11beta,17alpha,21-triol
1-Dehydrocortisol
1-Dehydrohydrocortisone
3,20-dioxo-11beta,17alpha,21-Trihydroxy-1,4-pregnadiene
46656_FLUKA
46656_RIEDEL
50-24-8
58201-11-9
8056-11-9
AC-1773
AC1L1L2E
Ak-Pred
Ak-Tate
Alphadrol
Articulose-50
BPBio1_000164
BRD-K98039984-001-03-0
BRN 1354103
BSPBio_000148
Bio-0666
Bubbli-Pred
C07369
CCRIS 980
CHEBI:8378
CHEMBL131
CID5755
CO-Hydeltra
CPD000718761
Co-Hydeltra
Codelcortone
Cordrol
Cortalone
Cotogesic
Cotolone
D00472
D011239
DB00860
Decaprednil
Decortin H
Delcortol
Delta F
Delta(1)-dehydrohydrocortisone
Delta-Cortef
Delta-Cortef (TN)
Delta-Ef-Cortelan
Delta-Stab
Delta-stab
Deltacortenol
Deltacortril
Deltacortril Enteric
Deltahydrocortisone
Deltasolone
Deltisilone
Depo-Medrol
Derpo PD
Derpo Pd
Dexa-Cortidelt Hostacortin H
Dexa-Cortidelt hostacortin H
Di Adreson F
Di-Adreson F
Di-Adreson-F
Di-adreson F
DiAdresonF
Dicortol
Donisolone
Dydeltrone
EINECS 200-021-7
Eazolin D
Econopred
Econopred Plus
Erbacort
Erbasona
Estilsona
Fernisolone
Fernisolone P
Fernisolone-P
Flamasone
HMS1568H10
HMS2090J05
HSDB 3385
Hostacortin H
Hydeltra
Hydeltra-Tba
Hydeltrasol
Hydeltrone
Hydrodeltalone
Hydrodeltisone
Hydroretrocortin
Hydroretrocortine
I-Pred
Inflamase Forte
Inflamase Mild
K 1557
Key-Pred
Klismacort
LMST02030179
LS-7669
Lentosone
Lite Pred
M-Predrol
 
MLS001304083
MLS002154250
MLS002207037
Medrol
Medrol Acetate
Metacortandralone
Methylprednisolone Acetate
Meti-Derm
Meticortelone
Metreton
MolPort-002-507-147
NCGC00179649-01
NSC 9120
NSC9120
NSC9900
Neo-Delta-Cortef
Nisolone
Nor-Pred T.B.A.
Ocu-Pred
Ocu-Pred Forte
Ophtho-Tate
Orapred
P0152_SIGMA
P0637
P6004_SIGMA
PRDL
PRED-G
Panafcortelone
Paracortol
Paracotol
Pediapred
Poly-Pred
Precortalon
Precortancyl
Precortilon
Precortisyl
Pred Forte
Pred Mild
Predair
Predair A
Predair Forte
Predalone 50
Predalone T.B.A.
Predate
Predate Tba
Predate-50
Predcor-25
Predcor-50
Predcor-Tba
Predisolone Sodium Phosphate
Predne-Dome
Prednelan
Predni-Dome
Prednicen
Predniliderm
Predniretard
Prednis
Prednisolona
Prednisolona [INN-Spanish]
Prednisolone (JP15/USP/INN)
Prednisolone (anhydrous)
Prednisolone Acetate
Prednisolone Sodium Phosphate
Prednisolone Tebutate
Prednisolone [INN:BAN:JAN]
Prednisolonum
Prednisolonum [INN-Latin]
Predonin
Predonine
Prelone
Prenolone
Prestwick0_000274
Prestwick1_000274
Prestwick2_000274
Prestwick3_000274
Prestwick_404
Rolisone
S1737_Selleck
SAM002264639
SMR000718761
SPBio_002367
Scherisolon
Solone
Steran
Sterane
Sterolone
Supercortisol
UNII-9PHQ9Y1OLM
Ulacort
Ultra Pred
Ultracorten H
Ultracortene H
Ultracortene-H
Ultracortene-Hydrogen
Ultracortene-hydrogen
ZINC03833821
component of Ataraxoid
component of K-Predne-Dome
delta(1)-Cortisol
delta(1)-Dehydrocortisol
delta(1)-Dehydrohydrocortisone
delta(1)-Hydrocortisone
delta(sup 1)-Cortisol
delta(sup 1)-Dehydrocortisol
delta(sup 1)-Dehydrohydrocortisone
delta(sup 1)-Hydrocortisone
delta-dehydrocortisol
delta-dehydrohydrocortisone
delta-hydrocortisone
prednisolone
11
Methylprednisoloneapproved, vet_approvedPhase 4115383-43-26741
Synonyms:
(6S,8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-17-(2-hydroxyacetyl)-6,10,13-trimethyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-one
(6a,11b)-11,17,21-Trihydroxy-6-methylpregna-1,4-diene-3,20-dione
(6alpha,11beta)-11,17,21-Trihydroxy-6-methylpregna-1,4-diene-3,20-dione
(6α,11β)-11,17,21-trihydroxy-6-methylpregna-1,4-diene-3,20-dione
.DELTA.1-6.alpha.-Methylhydrocortisone
1-Dehydro-6alpha-methylhydrocortisone
1-dehydro-6alpha-Methylhydrocortisone
1-dehydro-6α-methylhydrocortisone
11-beta,17,21-Trihydroxy-6-alpha-methylpregna-1,4-diene-3,20-dione
11beta,17,21-Trihydroxy-6alpha-methylpregna-1,4-diene-3,20-dione
11beta,17alpha,21-Trihydroxy-6alpha-methyl-1,4-pregnadiene-3,20-dione
11beta,17alpha,21-Trihydroxy-6alpha-methylpregna-1,4-diene-3,20-dione
121673-01-6
4-08-00-03498 (Beilstein Handbook Reference)
46436_FLUKA
46436_RIEDEL
570-35-4
6 Methylprednisolone
6-Methylprednisolone
6-alpha-Methylprednisolone
6.alpha.-Methylprednisolone
6923-42-8
6alpha-Methyl-11beta,17alpha,21-trihydroxy-1,4-pregnadiene-3,20-dione
6alpha-Methyl-11beta,17alpha,21-triol-1,4-pregnadiene-3,20-dione
6alpha-Methylprednisolone
6alpha-methyl-11beta,17alpha,21-triol-1,4-pregnadiene-3,20-dione
83-43-2
AC1L1N7A
Artisone-Wyeth
Artisone-wyeth
BPBio1_000174
BRD-K35240538-001-03-1
BRN 2340300
BSPBio_000158
Besonia
Bio-0658
CHEBI:6888
CHEMBL650
CID6741
CPD000058330
D00407
D008775
DB00959
Depo-Medrol (acetate)
Dopomedrol
EINECS 201-476-4
Esametone
Firmacort
HMS1568H20
HMS2090B13
HSDB 3127
LMST02030178
LS-118498
Lemod
M0639_SIGMA
M1665
MEPRDL
MLS000028541
MLS001148159
MLS002207191
Medesone
Medixon
Medlone 21
 
Medrate
Medrol
Medrol (TN)
Medrol Adt Pak
Medrol Dosepak
Medrol adt pak
Medrol dosepak
Medrol, Solu-Medrol, Medrone, Methylprednisolone
Medrone
Mesopren
Metastab
Methyleneprednisolone
Methylprednisolon
Methylprednisolone
Methylprednisolone (JP15/USP/INN)
Methylprednisolone [USAN:INN:BAN:JAN]
Methylprednisolone, 6-alpha
Methylprednisolonum
Methylprednisolonum [INN-Latin]
Metilbetasone
Metilprednisolona
Metilprednisolona [INN-Spanish]
Metilprednisolone
Metilprednisolone [DCIT]
Metilprednisolone [Dcit]
Metipred
Metrisone
Metrocort
Metysolon
Moderin
MolPort-002-528-554
NCGC00022735-03
NCI60_001657
NSC-19987
NSC19987
Nirypan
Noretona
Predni N Tablinen
Prednol- L
Pregna-1,4-diene-3,20-dione, 11beta,17,21-trihydroxy-6alpha-methyl- (8CI)
Prestwick0_000279
Prestwick1_000279
Prestwick2_000279
Prestwick3_000279
Prestwick_622
Promacortine
Reactenol
S1733_Selleck
SAM002589984
SMR000058330
SPBio_002377
Sieropresol
Solomet
Summicort
Suprametil
U 7532
UNII-X4W7ZR7023
Urbason
Urbasone
Wyacort
ZINC03875560
delta(1)-6alpha-Methylhydrocortisone
delta(sup 1)-6-alpha-Methylhydrocortisone
methylprednisolone
methylprenisolone
12Anti-Bacterial AgentsPhase 4, Phase 3, Phase 2, Phase 110884
13Anti-Infective AgentsPhase 4, Phase 3, Phase 2, Phase 121402
14AntimalarialsPhase 4, Phase 3, Phase 21216
15Antiparasitic AgentsPhase 4, Phase 3, Phase 22127
16Antiprotozoal AgentsPhase 4, Phase 3, Phase 21986
17Erythromycin stearatePhase 495
18Erythromycin EstolatePhase 495
19Erythromycin EthylsuccinatePhase 495
20penicillinsPhase 4109
21Antirheumatic AgentsPhase 410627
22cefuroxime axetilPhase 455
23Cytochrome P-450 CYP3A InhibitorsPhase 41666
24Antitubercular AgentsPhase 4, Phase 21272
25Cytochrome P-450 Enzyme InhibitorsPhase 43822
26Antibiotics, AntitubercularPhase 4, Phase 3, Phase 2, Phase 16972
27Peripheral Nervous System AgentsPhase 422776
28Neuroprotective AgentsPhase 41672
29Methylprednisolone HemisuccinatePhase 41153
30Prednisolone phosphatePhase 41153
31Methylprednisolone acetatePhase 41153
32Protective AgentsPhase 47190
33Prednisolone hemisuccinatePhase 41153
34Prednisolone acetatePhase 41153
35HormonesPhase 413979
36Autonomic AgentsPhase 49774
37Antineoplastic Agents, HormonalPhase 45407
38Hormones, Hormone Substitutes, and Hormone AntagonistsPhase 412767
39Gastrointestinal AgentsPhase 4, Phase 18109
40Anti-Inflammatory AgentsPhase 410355
41AntiemeticsPhase 43888
42Hormone AntagonistsPhase 412778
43glucocorticoidsPhase 44920
44
Minocyclineapproved, investigationalPhase 322410118-90-85281021
Synonyms:
(2Z,4S,4aS,5aR,12aS)-2-[amino(hydroxy)methylidene]-4,7-bis(dimethylamino)-10,11,12a-trihydroxy-4a,5,5a,6-tetrahydro-4H-tetracene-1,3,12-trione
(4S,4AS,5AR,12AS)-4,7-BIS(DIMETHYLAMINO)-3,10,12,12A-TETRAHYDROXY-1,11-DIOXO-1,4,4A,5,5A,6,11,12A-OCTAHYDROTETRACENE-2-CARBOXAMIDE
(4S,4AS,5ar,12as)-4,7-bis(dimethylamino)-3,10,12,12a-tetrahydroxy-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2-carboxamide
10118-90-8
13614-98-7 (mono-hydrochloride)
4,7-Bis(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,10,12,12a-tetrahydroxy-1,11-dioxo-2-naphthacenecarboxamide
4708-96-7
7-Dimethylamino-6-demethyl-6-deoxytetracycline
AC1NQXWM
BRN 3077644
Bio-0062
Borymycin
C07225
C23H27N3O7
CHEBI:50694
CHEBI:529981
CHEMBL1434
CHEMBL259172
CID5281021
CL 59806
CRL-1605 & Minocycline
D05045
HMS2090D03
HSDB 3130
 
LMPK07000002
LS-93850
Lactoferrin B & Minocycline
Lactoferrin H & Minocycline
MINO
MIY
Minociclina
Minociclina [INN-Spanish]
Minociclinum
Minocin
Minocin (Hydrochloride)
Minocline
Minocyclin
Minocycline (USAN/INN)
Minocycline Monohydrochloride
Minocycline [USAN:BAN:INN]
Minocyclinum
Minocyclinum [INN-Latin]
NCGC00178854-01
NSC 141993
NSC141993
UNII-FYY3R43WGO
Vectrin (Hydrochloride)
minociclinum
minocycline
nchembio.559-comp1
45
Permethrinapproved, investigationalPhase 33352645-53-140326
Synonyms:
(+)-CIS-PERMETHRIN
(+)-trans-Permethrin
(+-)-cis-Fmc 33297
(+-)-cis-Permethrin
(+-)-trans-Permethrin
(3-Phenoxyphenyl)methyl (+-)-cis,trans-3-(2,2-dichloroethenyl)-2,2-dimethylcyclopropanecarboxylate
(3-phenoxyphenyl)methyl 3-(2,2-dichloroethenyl)-2,2-dimethylcyclopropane-1-carboxylate
1RS,cis-Permethrin
1RS-trans-Permethrin
3-(2,2-Dichloroethenyl)-2,2-dimethylcyclopropane carboxylic acid, (3-phenoxyphenyl) methyl ester
3-Phenoxybenzyle (1RS)-cis, trans-3-(2,2-dichlorovinyl)-2,2-dimethylcyclopropane carboxylate
3-phenoxybenzyl 3-(2,2-dichloroethenyl)-2,2-dimethylcyclopropanecarboxylate
442748_SUPELCO
45614_FLUKA
45614_RIEDEL
45893_FLUKA
45893_RIEDEL
47956_SUPELCO
52341-32-9
52341-33-0
52645-53-1
AC1L23IC
AC1Q3FFG
AI3-29296
Acticin Cream
Ambush
BRN 4153590
C21H20Cl2O3
CHEBI:34911
CHEMBL1525
CID40326
 
DB04930
Elimite Cream
FMC 35171
LS-58636
LS-58640
MLS001332525
MLS001332526
MolPort-003-933-021
NCGC00159390-00
NCGC00159390-02
NCGC00159390-04
NCGC00159390-05
NCGC00159390-06
NCGC00159390-07
NCGC00159390-08
NCGC00159390-09
NRDC 146
NRDC 148
Nix Cream Rinse
PS758_SUPELCO
PerFoam
Permethrin
Permethrin (isomers)
Permethrin (isomers) solution
Permethrine,c&t
SMR000778043
ST50975270
TL8003462
Transpermethrin
Transpermethrin [ISO]
[3-(phenyloxy)phenyl]methyl 3-(2,2-dichloroethenyl)-2,2-dimethylcyclopropanecarboxylate
trans-(+-)-Permethrin
46
OsimertinibapprovedPhase 3521421373-65-071496458
Synonyms:
Mereletinib
 
N-(2-{[2-(dimethylamino)ethyl](methyl)amino}-4-methoxy-5-{[4-(1-methyl-1H-indol-3-yl)pyrimidin-2-yl]amino}phenyl)prop-2-enamide
Tagrisso
mereletinib
47VaccinesPhase 3, Phase 1, Phase 26428
48Protein Kinase InhibitorsPhase 33612
49MitogensPhase 31526
50PENTAPhase 3109

Interventional clinical trials:

(show top 50)    (show all 61)
idNameStatusNCT IDPhase
1Study of Lyme NeuroborreliosisUnknown statusNCT01635530Phase 4
2Persistent Lyme Empiric Antibiotic Study EuropeCompletedNCT01207739Phase 4
3Comparing 3 Antibiotic Regimes for Erythema Migrans in General PracticeCompletedNCT01368341Phase 4
4Comparison of Doxycycline and Cefuroxime Axetil for Treatment of Erythema Migrans: Clinical and Microbiological OutcomeCompletedNCT01518192Phase 4
5Aizthromycin or Clarithromycin in H-pylori Eradication RegimenCompletedNCT01667692Phase 4
6The Study to Treat Superficial Femoral Artery Occlusions.CompletedNCT00232843Phase 4
7Injection Versus Splinting in Carpal Tunnel SyndromeRecruitingNCT02038452Phase 4
8Minocycline Therapy for Lung Scarring in Patients With Idiopathic Pulmonary Fibrosis - a Pilot StudyUnknown statusNCT00203697Phase 3
9A Randomized, Double-Blind, Placebo-Controlled, Multicenter Trial of the Safety and Efficacy of Ceftriaxone and Doxycycline in the Treatment of Patients With Seropositive Chronic Lyme DiseaseCompletedNCT00001101Phase 3
10A Randomized, Double-Blind, Placebo-Controlled, Multicenter Trial of the Safety and Efficacy of Ceftriaxone and Doxycycline in the Treatment of Patients With Seronegative Chronic Lyme DiseaseCompletedNCT00000938Phase 3
11Study and Treatment of Post Lyme Disease (STOP-LD)CompletedNCT00000937Phase 3
12Lyme Disease Prevention ProgramCompletedNCT00000432Phase 3
13Post Exposure Treatment With Doxycycline for the Prevention of Relapsing FeverCompletedNCT00237016Phase 2, Phase 3
14Effect of Intravenous Ceftriaxone and Oral Doxycycline for Lyme NeuroborreliosisCompletedNCT00138801Phase 3
15Safety Evaluation of Herpes Simplex Candidate Vaccine (gD2t) With Adjuvant in HSV Seropositive / Seronegative SubjectsCompletedNCT00698568Phase 3
16Benralizumab Efficacy in Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD) With Exacerbation HistoryRecruitingNCT02138916Phase 3
17Real World Treatment Study of AZD9291 for Advanced/Metastatic EGFR T790M Mutation NSCLCRecruitingNCT02474355Phase 3
18Six Versus Two Weeks Treatment With Doxycycline in Lyme NeuroborreliosisEnrolling by invitationNCT02553473Phase 3
19Passive Prophylaxis of Lyme Disease Using Permethrin Treated ClothesTerminatedNCT00958139Phase 3
20A Placebo-controlled Efficacy Study of IV Ceftriaxone for Refractory PsychosisUnknown statusNCT00591318Phase 1, Phase 2
21Phase 1/2 Lyme Vaccine StudyCompletedNCT01504347Phase 1, Phase 2
22Safety, Skin and Plasma Concentration of Azithromycin Dermal FormulationCompletedNCT01243008Phase 1, Phase 2
23Brain Imaging and Retreatment Study of Persistent Lyme DiseaseCompletedNCT00037479Phase 2
24Antibiotic Treatment Trial for the PANDAS/PANS PhenotypeCompletedNCT01617083Phase 2
25Efficacy of 1072nm Infrared Stimulation on Executive Functioning in DementiaCompletedNCT01059877Phase 1, Phase 2
26Xenodiagnosis After Antibiotic Treatment for Lyme DiseaseRecruitingNCT02446626Phase 1, Phase 2
27A Clinical Trial of the Clinical Effects of Hyperbaric Oxygen Therapy in Thai Autistic ChildrenCompletedNCT00670891Phase 1
28Study Assessing the Safety, Immunogenicity and Dose Response of VLA15, A New Vaccine Candidate Against Lyme BorreliosisNot yet recruitingNCT03010228Phase 1
29Human Anaplasmosis in Eastern FranceUnknown statusNCT01013636
30Doxycycline and Ceftriaxone in Suspected Early Lyme NeuroborreliosisUnknown statusNCT00942006
31Meditation and Stretching for Post Treatment Lyme Disease SyndromeUnknown statusNCT02344537
32300 Antibody Diagnostic Test KitUnknown statusNCT01646411
33Doxycycline in Therapy of Erythema MigransCompletedNCT01475708
34Duration of Antibiotic Treatment of Erythema MigransCompletedNCT00910715
35The Phenomenon of "Chronic Lyme"; an Observational StudyCompletedNCT01151150
36Microbiologic Findings of Acute Facial Palsy in ChildrenCompletedNCT01537952
37Culture Media for Borrelia Burgdorferi Sensu LatoCompletedNCT02145754
38Searching for Persistence of Infection in Lyme DiseaseCompletedNCT01143558Early Phase 1
39Rapid Diagnostic Tests and Clinical/Laboratory Predictors of Tropical Diseases In Patients With Persistent Fever in Cambodia, Nepal, Democratic Republic of the Congo and Sudan (NIDIAG-Fever)CompletedNCT01766830
40Study of Anti-HIV Therapy IntensificationCompletedNCT00034086
41Borrelia Species in Cutaneous Lyme BorreliosisRecruitingNCT00576082
42Lyme Borreliosis and Early Cutaneous DiagnosticRecruitingNCT02414789
43Study on Early Lyme NeuroborreliosisRecruitingNCT00910533
44Tick-borne Encephalitis and Positive Borrelial AntibodiesRecruitingNCT02463942
45Cytokines and Chemokines in Erythema MigransRecruitingNCT02147249
46Laboratory Characteristics in Chronic Atrophic AcrodermatitisRecruitingNCT02147262
47Evaluation of Lyme Disease: Clinical, Microbiological and Immunological CharacteristicsRecruitingNCT00001539
48Evaluation, Treatment, and Follow-up of Patients With Lyme DiseaseRecruitingNCT00028080
49A Multicenter Study to Evaluate a Borrelia Diagnostic Test in Subjects With Early Stage or Late Stage Lyme DiseaseRecruitingNCT02741609
50Analysis of Lyme Disease LesionsRecruitingNCT00132327

Search NIH Clinical Center for Lyme Disease


Cochrane evidence based reviews: lyme neuroborreliosis

Genetic Tests for Lyme Disease

About this section

Anatomical Context for Lyme Disease

About this section

MalaCards organs/tissues related to Lyme Disease:

36
Skin, Testes, Heart, Eye, Brain, Lung, T cells

Publications for Lyme Disease

About this section

Articles related to Lyme Disease:

(show top 50)    (show all 765)
idTitleAuthorsYear
1
Succinyl-I^-cyclodextrin modified gold biochip improved seroimmunological detection sensitivity for Lyme disease. (28010742)
2017
2
Environmental Factors Affecting Survival of Immature Ixodes scapularis and Implications for Geographical Distribution of Lyme Disease: The Climate/Behavior Hypothesis. (28076359)
2017
3
Use of a tick-borne disease manual increases accuracy of tick identification among primary care providers in Lyme disease endemic areas. (27916581)
2017
4
A critical appraisal of the mild axonal peripheral neuropathy of late neurologic Lyme disease. (27914746)
2017
5
Lyme disease risk in southern California: abiotic and environmental drivers of Ixodes pacificus (Acari: Ixodidae) density and infection prevalence with Borrelia burgdorferi. (28057067)
2017
6
Comparison of Vector Efficiency of Ixodes scapularis (Acari: Ixodidae) From the Northeast and Upper Midwest of the United States for the Lyme Disease Spirochete Borrelia mayonii. (28082653)
2017
7
Temperature-dependent sRNA transcriptome of the Lyme disease spirochete. (28056764)
2017
8
TH17 Cytokine Responses in Lyme Disease Correlate with Borreliaburgdorferi Antibodies During Early Infection in Patients with Erythema Migrans and with Autoantibodies Late in the Illness in Patients with Antibiotic-Refractory Lyme Arthritis. (28077518)
2017
9
Lyme Disease Presenting with Multiple Cranial Nerve Deficits: Report of a Case. (27635267)
2016
10
Nested coevolutionary networks shape the ecological relationships of ticks, hosts, and the Lyme disease bacteria of the Borrelia burgdorferi (s.l.) complex. (27662832)
2016
11
Borrelia sp. phylogenetically different from Lyme disease- and relapsing fever-related Borrelia spp. in Amblyomma varanense from Python reticulatus. (27342652)
2016
12
Long-term Follow-up of Patients With Lyme Disease: Longitudinal Analysis of Clinical and Quality-of-life Measures. (27025825)
2016
13
Lyme Disease in West Virginia: An Assessment of Distribution and Clinicians' Knowledge of Disease and Surveillance. (27491103)
2016
14
Susceptibility, likelihood to be diagnosed, worry and fear for contracting Lyme disease. (27026135)
2016
15
A Case of Lyme Disease Accompanied by Uveitis and White Dot Syndrome. (28058168)
2016
16
Community Partnership Designed to Promote Lyme Disease Prevention and Engagement in Citizen Science. (27047593)
2016
17
Sequential Insults: Acute Lyme Disease with Splenic Infarction. (26688425)
2016
18
Statins reduce spirochetal burden and modulate immune responses in the C3H/HeN mouse model of Lyme disease. (26993029)
2016
19
Human Granulocytic Anaplasmosis and Lyme Disease--Reply. (27380351)
2016
20
Lyme disease and relapsing fever Borrelia elongate through zones of peptidoglycan synthesis that mark division sites of daughter cells. (27506799)
2016
21
Antibody profiling of canine IgG responses to the OspC protein of the Lyme disease spirochetes supports a multivalent approach in vaccine and diagnostic assay development. (27938705)
2016
22
Lyme disease. (27650153)
2016
23
Expression of C-Reactive Protein and Serum Amyloid A in Early to Late Manifestations of Lyme Disease. (27585799)
2016
24
Lyme Disease. (27136224)
2016
25
Lyme disease or a lemon? (27989005)
2016
26
Intentions to receive a potentially available Lyme disease vaccine in an urban sample. (27551427)
2016
27
Lyme disease risk in dogs in New Brunswick. (27587892)
2016
28
Diagnosis of Lyme disease in the pediatric acute care setting. (27138805)
2016
29
Co-feeding transmission facilitates strain coexistence in Borrelia burgdorferi, the Lyme disease agent. (28089780)
2016
30
Comparison of the lifetime host-to-tick transmission between two strains of the Lyme disease pathogen Borrelia afzelii. (27986081)
2016
31
Analysis of the human population bitten by Ixodes scapularis ticks in Quebec, Canada: Increasing risk of Lyme disease. (27650641)
2016
32
Longer-Term Therapy for Symptoms Attributed to Lyme Disease. (27602674)
2016
33
Seroprevalence of Babesia microti in Individuals with Lyme Disease. (27911694)
2016
34
Live-vaccinia virus encapsulation in pH-sensitive polymer increases safety of a reservoir-targeted Lyme disease vaccine by targeting gastrointestinal release. (27502570)
2016
35
Longer-Term Therapy for Symptoms Attributed to Lyme Disease. (27602675)
2016
36
Ceftriaxone-induced immune hemolytic anemia as a life-threatening complication of antibiotic treatment of 'chronic Lyme disease'. (27169474)
2016
37
Steroid use in Lyme disease-associated facial palsy is associated with worse long-term outcomes. (27598389)
2016
38
Transplantation of Human Embryonic Stem Cells in Patients with Multiple Sclerosis and Lyme Disease. (27956736)
2016
39
Lyme Disease Surveillance in New York State: an Assessment of Case Underreporting. (27612955)
2016
40
Autoimmune Arthritides, Rheumatoid Arthritis, Psoriatic Arthritis, or Peripheral Spondyloarthropathy, Following Lyme Disease. (27636905)
2016
41
Longer-Term Therapy for Symptoms Attributed to Lyme Disease. (27602673)
2016
42
Interaction of the Lyme disease spirochete with its tick vector. (27147446)
2016
43
Cyclic-di-GMP binding induces structural rearrangements in the PlzA and PlzC proteins of the Lyme disease and relapsing fever spirochetes: a possible switch mechanism for c-di-GMP-mediated effector functions. (27852620)
2016
44
Human Granulocytic Anaplasmosis and Lyme Disease. (27380349)
2016
45
Treatment of Lyme disease. (27148921)
2016
46
Time for a Different Approach to Lyme Disease and Long-Term Symptoms. (27028918)
2016
47
False Positive Lyme Disease IgM Immunoblots in Children. (27157898)
2016
48
Yamamoto New Scalp Acupuncture, Applied Kinesiology, and Breathing Exercises for Facial Paralysis in a Young Boy Caused by Lyme Disease-A Case Report. (27102135)
2016
49
Cimetidine as a novel adjunctive treatment for early stage Lyme disease. (27107653)
2016
50
Diagnosis, Treatment, and Prevention of Lyme Disease, Human Granulocytic Anaplasmosis, and Babesiosis: A Review. (27115378)
2016

Variations for Lyme Disease

About this section

Expression for genes affiliated with Lyme Disease

About this section
Search GEO for disease gene expression data for Lyme Disease.

Pathways for genes affiliated with Lyme Disease

About this section

Pathways related to Lyme Disease according to GeneCards Suite gene sharing:

(show all 45)
idSuper pathwaysScoreTop Affiliating Genes
19.7IL1B, IL6
29.5IL1B, TNF
39.3CD40LG, IL1B, TNF
49.2IL1B, TLR2, TNF
59.2IL1B, IL6, TNF
69.2IL1B, IL6, TNF
79.2IL1B, IL6, TNF
89.2IL1B, IL6, TNF
99.2IL1B, IL6, TNF
109.2IL1B, IL6, TNF
119.2IL1B, IL6, TNF
129.1IL6, MMP9, TNF
139.0CD40LG, IL6, TLR2, TNF
14
Show member pathways
9.0IL17A, IL6, TLR2
158.9C3, TLR1, TLR2, TLR6
168.8IL1B, IL6, TLR2, TNF
17
Show member pathways
8.8IL1B, TLR1, TLR2, TLR6
188.8C3, IL1B, IL6, TNF
198.7HSPD1, IL1B, IL6, TNF
208.7IL17A, IL1B, TNF
218.6IL1B, IL6, MMP9, TNF
228.6IL1B, IL6, MMP9, TNF
238.6CD40LG, IL1B, IL6, TLR2, TNF
24
Show member pathways
8.6C3, CD40LG, IL1B, TLR2, TNF
25
Show member pathways
8.5CD40LG, TLR1, TLR2, TLR6, TNF
26
Show member pathways
8.5C3, IL1B, IL6, TLR2, TNF
27
Show member pathways
8.3IL17A, IL1B, IL6, TNF
28
Show member pathways
8.3IL17A, IL1B, IL6, TNF
298.1CD40LG, IL17A, IL1B, IL6, TNF
30
Show member pathways
8.1CD40LG, IL17A, IL1B, IL6, TNF
318.0C3, HSPD1, IL1B, IL6, TLR2, TNF
328.0CD40LG, IL1B, TLR1, TLR2, TLR6, TNF
33
Show member pathways
8.0CD40LG, IL1B, TLR1, TLR2, TLR6, TNF
348.0IL17A, IL1B, IL6, TLR2, TNF
35
Show member pathways
7.9IL1B, IL6, TLR1, TLR2, TLR6, TNF
36
Show member pathways
7.9IL1B, IL6, TLR1, TLR2, TLR6, TNF
377.9IL6, MMP9, TLR1, TLR2, TLR6, TNF
38
Show member pathways
7.7CD40LG, IL1B, IL6, TLR1, TLR2, TLR6
39
Show member pathways
7.6IL17A, IL1B, IL6, TLR1, TLR2, TLR6
40
Show member pathways
7.4CD40LG, HSPD1, IL17A, IL1B, IL6, TLR2
417.1C3, HSPD1, IL1B, IL6, TLR1, TLR2
42
Show member pathways
7.1IL17A, IL1B, IL6, TLR1, TLR2, TLR6
43
Show member pathways
7.0C3, IL1B, IL6, MMP9, TLR1, TLR2
44
Show member pathways
6.9CD40LG, IL17A, IL1B, IL6, TLR1, TLR2
45
Show member pathways
6.2C3, CD40LG, CFH, IL17A, IL1B, IL6

GO Terms for genes affiliated with Lyme Disease

About this section

Cellular components related to Lyme Disease according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1Toll-like receptor 1-Toll-like receptor 2 protein complexGO:00353549.9TLR1, TLR2
2external side of plasma membraneGO:00098979.3CD40LG, IL17A, IL6, TNF
3phagocytic vesicle membraneGO:00306709.2TLR1, TLR2, TLR6
4membrane raftGO:00451218.8HSPD1, TLR1, TLR2, TLR6, TNF
5extracellular regionGO:00055767.9C3, CFH, IL17A, IL1B, IL6, MMP9
6extracellular spaceGO:00056156.9C3, CD40LG, CFH, CFHR1, HSPD1, IL17A

Biological processes related to Lyme Disease according to GeneCards Suite gene sharing:

(show top 50)    (show all 55)
idNameGO IDScoreTop Affiliating Genes
1cellular response to triacyl bacterial lipopeptideGO:007172710.6TLR1, TLR2
2detection of triacyl bacterial lipopeptideGO:004249510.6TLR1, TLR2
3complement activation, alternative pathwayGO:000695710.6C3, CFH
4epithelial cell proliferation involved in salivary gland morphogenesisGO:006066410.4IL6, TNF
5complement activationGO:000695610.4C3, CFH, CFHR1
6negative regulation of lipid storageGO:001088810.4IL6, TNF
7regulation of immunoglobulin secretionGO:005102310.4CD40LG, TNF
8cellular response to diacyl bacterial lipopeptideGO:007172610.3TLR2, TLR6
9detection of diacyl bacterial lipopeptideGO:004249610.3TLR2, TLR6
10nitric oxide metabolic processGO:004620910.3TLR2, TLR6
11chronic inflammatory response to antigenic stimulusGO:000243910.3IL1B, TNF
12negative regulation of lipid catabolic processGO:005099510.2IL1B, TNF
13positive regulation of calcidiol 1-monooxygenase activityGO:006055910.2IL1B, TNF
14positive regulation of chemokine biosynthetic processGO:004508010.2IL1B, TNF
15positive regulation of fever generationGO:003162210.2IL1B, TNF
16positive regulation of interleukin-10 productionGO:003273310.2CD40LG, HSPD1, TLR2
17positive regulation of interleukin-12 productionGO:003273510.2CD40LG, HSPD1, TLR2
18positive regulation of heterotypic cell-cell adhesionGO:003411610.2IL1B, TNF
19positive regulation of membrane protein ectodomain proteolysisGO:005104410.2IL1B, TNF
20response to bacterial lipoproteinGO:003249310.2TLR2, TLR6
21regulation of establishment of endothelial barrierGO:190314010.1IL1B, TNF
22regulation of I-kappaB kinase/NF-kappaB signalingGO:004312210.1IL1B, TNF
23response to coldGO:000940910.1HSPD1, IL6, YBX3
24positive regulation of T cell proliferationGO:004210210.1CD40LG, IL1B, IL6
25defense response to Gram-positive bacteriumGO:005083010.1IL6, TLR2, TNF
26positive regulation of chemokine productionGO:003272210.0IL6, TLR2, TNF
27toll-like receptor TLR1:TLR2 signaling pathwayGO:00381239.9TLR1, TLR2
28lipopolysaccharide-mediated signaling pathwayGO:00316639.9IL1B, TLR2, TNF
29sequestering of triglycerideGO:00307309.9IL1B, TNF
30regulation of cytokine secretionGO:00507079.9TLR1, TLR2, TLR6
31positive regulation of interleukin-8 productionGO:00327579.9IL1B, TLR2, TNF
32positive regulation of NF-kappaB import into nucleusGO:00423469.9IL1B, TLR2, TNF
33response to heatGO:00094089.9HSPD1, IL1B, IL6
34positive regulation of nitric oxide biosynthetic processGO:00454299.8IL1B, IL6, TNF
35positive regulation of interleukin-6 biosynthetic processGO:00454109.8IL1B, TLR1, TLR6
36positive regulation of sequence-specific DNA binding transcription factor activityGO:00510919.8IL1B, IL6, TNF
37positive regulation of phagocytosisGO:00507669.8C3, IL1B, TNF
38positive regulation of interferon-gamma productionGO:00327299.8HSPD1, IL1B, TNF
39leukocyte migrationGO:00509009.7IL1B, MMP9, TNF
40MyD88-dependent toll-like receptor signaling pathwayGO:00027559.6HSPD1, TLR1, TLR2, TLR6
41positive regulation of JUN kinase activityGO:00435079.6IL1B, TLR6, TNF
42positive regulation of gene expressionGO:00106289.5IL1B, IL6, TLR2, TNF
43toll-like receptor TLR6:TLR2 signaling pathwayGO:00381249.5TLR2, TLR6
44positive regulation of ERK1 and ERK2 cascadeGO:00703749.5C3, IL1B, IL6, TNF
45positive regulation of interleukin-6 secretionGO:20007789.5HSPD1, IL17A, IL1B
46negative regulation of apoptotic processGO:00430669.5CD40LG, HSPD1, IL6, MMP9, YBX3
47response to glucocorticoidGO:00513849.4C3, HSPD1, IL6, TNF
48toll-like receptor signaling pathwayGO:00022249.4TLR1, TLR2, TLR6
49response to lipopolysaccharideGO:00324969.4HSPD1, IL1B, IL6, TLR2
50positive regulation of NF-kappaB transcription factor activityGO:00510929.3CD40LG, IL1B, IL6, TLR2, TNF

Molecular functions related to Lyme Disease according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1Toll-like receptor 2 bindingGO:00356639.6TLR1, TLR6
2lipopeptide bindingGO:00717239.3TLR1, TLR2, TLR6
3cytokine activityGO:00051258.3CD40LG, IL17A, IL1B, IL6, TNF

Sources for Lyme Disease

About this section
2CDC
6CNVD
10DGIdb
15ExPASy
16FDA
17FMA
27GTR
28HGMD
29HMDB
30ICD10
31ICD10 via Orphanet
32ICD9CM
33IUPHAR
34KEGG
37MedGen
39MeSH
40MESH via Orphanet
41MGI
44NCI
45NCIt
46NDF-RT
49NINDS
50Novoseek
52OMIM
53OMIM via Orphanet
57PubMed
58QIAGEN
63SNOMED-CT via Orphanet
67Tumor Gene Family of Databases
68UMLS
69UMLS via Orphanet